Related Experiment Video
Updated: Feb 25, 2026
05:46
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
2.2K
Brachytherapy and anterior segment imaging in iris melanoma
Jin Soo Andy Song1, Adam A Dmytriw2, Hesham Lakosha1
1Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada.
Oman Journal of Ophthalmology
|August 1, 2017
Summary
Ultrasound biomicroscopy effectively aids in diagnosing and monitoring uveal lesions, including iris melanoma. This case highlights its role in guiding I-131 brachytherapy for aggressive BAP-1 mutated iris melanoma.
Area of Science:
- Ophthalmology
- Medical Imaging
- Oncology
Background:
- Ultrasound biomicroscopy (UBM) is crucial for diagnosing and characterizing uveal lesions.
- UBM assists in assessing the placement and response to brachytherapy for malignant uveal tumors.
Purpose of the Study:
- To present a case of iris melanoma with BAP-1 mutation treated with I-131 brachytherapy.
- To illustrate the role of UBM in characterizing and following such cases.
- To discuss the current utility of UBM in managing uveal lesions.
Main Methods:
- Case report of iris melanoma with BAP-1 mutation.
- Treatment with I-131 brachytherapy.
- Characterization and follow-up using Ultrasound Biomicroscopy (UBM).
Main Results:
- Successful treatment of iris melanoma with I-131 brachytherapy.
- UBM confirmed lesion characteristics and response to treatment.
- Demonstrated the value of UBM in managing complex uveal melanoma cases.
Conclusions:
- UBM is a valuable tool for uveal lesion diagnosis and management.
- UBM plays a key role in monitoring brachytherapy effectiveness for iris melanoma.
- This case underscores the successful application of UBM and brachytherapy for aggressive iris melanoma.
